BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 3290716)

  • 1. A closer look at plasmapheresis in multiple sclerosis: the cons.
    Tindall R
    Neurology; 1988 Jul; 38(7 Suppl 2):53-6. PubMed ID: 3290716
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Experience with use of plasmapheresis in chronic progressive multiple sclerosis: the pros.
    Khatri BO
    Neurology; 1988 Jul; 38(7 Suppl 2):50-2. PubMed ID: 3290715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Plasmapheresis: its use in multiple sclerosis and other demyelinating processes of the central nervous system. An observation study].
    Meca-Lallana JE; Rodríguez-Hilario H; Martínez-Vidal S; Saura-Luján I; Carretón-Ballester A; Escribano-Soriano JB; Martín-Fernández J; Genovés-Aleixandre A; Mateo-Bosch E; Fernández-Barreiro A
    Rev Neurol; 2003 Nov 16-30; 37(10):917-26. PubMed ID: 14634919
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The problem and value of therapy in multiple sclerosis].
    Hitzschke B; Meyer-Rienecker HJ; Buddenhagen F; Richter M
    Psychiatr Neurol Med Psychol (Leipz); 1988 Oct; 40(10):598-608. PubMed ID: 3237866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Azathioprine in multiple sclerosis: the cons.
    Silberberg DH
    Neurology; 1988 Jul; 38(7 Suppl 2):24-7. PubMed ID: 3290710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasmapheresis and acute Guillain-Barré syndrome. The Guillain-Barré syndrome Study Group.
    Neurology; 1985 Aug; 35(8):1096-104. PubMed ID: 4022342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thymectomy in multiple sclerosis. Two preliminary trials.
    Ferguson TB; Clifford DB; Montgomery EB; Bruns KA; McGregor PJ; Trotter JL
    J Thorac Cardiovasc Surg; 1983 Jan; 85(1):88-93. PubMed ID: 6848891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic plasma exchange in patients with neurologic diseases: retrospective multicenter study.
    Kaynar L; Altuntas F; Aydogdu I; Turgut B; Kocyigit I; Hacioglu SK; Ismailogullari S; Turgut N; Erkurt MA; Sari I; Oztekin M; Solmaz M; Eser B; Ersoy AO; Unal A; Cetin M
    Transfus Apher Sci; 2008 Apr; 38(2):109-15. PubMed ID: 18331814
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The potential use of adult stem cells for the treatment of multiple sclerosis and other neurodegenerative disorders.
    Slavin S; Kurkalli BG; Karussis D
    Clin Neurol Neurosurg; 2008 Nov; 110(9):943-6. PubMed ID: 18325660
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Combined therapy in multiple sclerosis].
    García-Merino JA; Blasco-Quítez MR; Ortiz-Benítez P; Puerta C
    Rev Neurol; 2003 Mar 16-31; 36(6):545-9. PubMed ID: 12652419
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [New therapeutic possibilities for disseminated sclerosis?].
    Wanscher B; Sørensen PS
    Ugeskr Laeger; 1994 Oct; 156(43):6353-8. PubMed ID: 7810008
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Experience with cyclophosphamide in multiple sclerosis: the cons.
    Likosky WH
    Neurology; 1988 Jul; 38(7 Suppl 2):14-8. PubMed ID: 3290708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Advances in the treatment of multiple sclerosis?].
    Tackenberg B; Himmerich H; Wellek A; Oertel WH; Sommer N
    MMW Fortschr Med; 2007 May; 149 Suppl 2():51-5. PubMed ID: 17724968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treating multiple sclerosis with monoclonal antibodies: the cons.
    Champlin RE
    Neurology; 1988 Jul; 38(7 Suppl 2):47-9. PubMed ID: 3260357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Plasmapheresis in multiple sclerosis].
    Fuchs S; Pogglitsch H; Ladurner G; Lechner H
    Wien Klin Wochenschr; 1984 Jan; 96(2):67-9. PubMed ID: 6710999
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical application and the technical procedure of plasmapheresis].
    Gurland HJ; Samtleben W
    Internist (Berl); 1983 Jan; 24(1):14-26. PubMed ID: 6341277
    [No Abstract]   [Full Text] [Related]  

  • 17. Stem cell transplantation for autoimmune disorders. Multiple sclerosis.
    Fassas A; Nash R
    Best Pract Res Clin Haematol; 2004 Jun; 17(2):247-62. PubMed ID: 15302338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The indication of steroid pulse therapy and apheresis therapy for multiple sclerosis].
    Ohji S; Nomura K
    Nihon Rinsho; 2008 Jun; 66(6):1127-32. PubMed ID: 18540358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasmapheresis therapy in myasthenia gravis.
    Dau PC
    Muscle Nerve; 1980; 3(6):468-82. PubMed ID: 7453714
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Double-blind study of true vs. sham plasmapheresis in patients being treated with immunosuppression for acute attacks of multiple sclerosis.
    Weiner HL; Dau PC; Khatri BO; Petajan J; Birnbaum G; McQuillen MP; Fosburg MT; Feldstein M; Orav J
    Prog Clin Biol Res; 1990; 337():283. PubMed ID: 2162062
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.